ZafrirBSalibaWJaffeR, et al.
Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery. Eur J Prev Cardiol2019;
26: 401–408.
2.
WangYYanBPTomlinsonB, et al.
Is lipid goal one-size-fits-all: a review of evidence for recommended low-density lipoprotein treatment targets in Asian patients. Eur J Prev Cardiol2019;
26: 1496–1506.
3.
CosteJBillionnetCRudnichiA, et al.
Statins for primary prevention and rhabdomyolysis: a nationwide cohort study in France. Eur J Prev Cardiol2019;
26: 512–521.
4.
SirtoriCRYamashitaSGrecoMF, et al. Recent advances in synthetic pharmacotherapies for dyslipidaemias. Eur J Prev Cardiol 2020; 27: 1576–1596.
5.
DaiLZuoYYouQ, et al. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol. Epub ahead of print 17 June 2020. 2047487320930585.
6.
LeeHParkJBHwangIC, et al.
Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naive young adults: a nationwide cohort study. Eur J Prev Cardiol2020;
27: 870–881.
7.
QuispeRElshazlyMBZhaoD, et al. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: the ARIC study. Eur J Prev Cardiol 2020; 27: 1597–1605.
8.
MadsenCMVarboANordestgaardBG.Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J2017;
38: 2478–2486.
9.
FengMDarabiMTubeufE, et al. Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease. Eur J Prev Cardiol 2020; 27: 1606–1616.
10.
ElshazlyMBManiPNissenS, et al.
Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease. Eur J Prev Cardiol2020;
27: 1091–1100. DOI: 10.1177/2047487319887578
11.
JoshiRWannametheeSGEngmannJ, et al. Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: a prospective analysis in 11,560 adults. Eur J Prev Cardiol 2020; 27: 1617–1626.
12.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188.
13.
De BacquerDDe SmedtDReinerZ, et al. Percentual LDL-C response to a given statin dose is not fixed across the pre-treatment range: real world evidence from clinical practice. Eur J Prev Cardiol 2020; 27: 1630–1636.
14.
SekeljSSandlerBJohnstonE, et al. Detecting undiagnosed atrial fibrillation in UK primary care: validation of a machine learning prediction algorithm in a retrospective cohort study. Eur J Prev Cardiol. Epub ahead of print 13 August 2020. DOI: 10.1177/2047487320942338
15.
PinaAHelgadottirSMancinaRM, et al. Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning. Eur J Prev Cardiol 2020; 27: 1639–1646.
16.
BesselingJHuttenBA.Is there a link between diabetes and cholesterol metabolism?Expert Rev Cardiovasc Ther2016;
14: 259–261.
17.
Perez-CalahorraS, et al. Behavioral cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolemia. Eur J Prev Cardiol 2020; 27: 1649–1660.
18.
Vallejo-VazAJLeiterLADel PratoS, et al. Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY Phase 3 trials with alirocumab. Eur J Prev Cardiol 2020; 27: 1663–1674.
